Vol. 19 No. 1 (2020)
Clinical Cases

Female patient with erythoderma, mucositis and pancytopenia

PDF (PT-BR)
  • Natasha Cytrynbaum,
  • André P. G. Machado
Natasha Cytrynbaum
Programa de Residência em Clínica Médica. Departamento de Clínica Médica. Faculdade de Ciências Médicas. Universidade do Estado do Rio de Janeiro, RJ, Brasil.
André P. G. Machado
. Departamento de Clínica Médica. Faculdade de Ciências Médicas. Universidade do Estado do Rio de Janeiro, RJ, Brasil.
DOI: https://doi.org/10.12957/bjhbs.2020.53535

Published 2020-07-01

Keywords

  • Erythroderma,
  • Mucositis,
  • Pancytopenia,
  • Methotrexate,
  • Pharmacodermia

How to Cite

1.
Natasha Cytrynbaum, André P. G. Machado. Female patient with erythoderma, mucositis and pancytopenia. BJHBS [Internet]. 2020 Jul. 1 [cited 2024 Oct. 11];19(1):69-73. Available from: https://bjhbs.hupe.uerj.br/bjhbs/article/view/115

Copyright (c) 2020 Brazilian Journal of Health and Biomedical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC

Abstract

A 31 year-old female patient with psoriasis on irregular treatment with methotrexate, folic acid, and cyclosporine presenting erythroderma associated with epidermal desquamation, mucositis and pancytopenia was admitted for investigation.

PDF (PT-BR)

Metrics

Metrics Loading ...

References

  1. Pal S, Haroon TS. Erythroderma: a clinico-etiologic study of 90 cases. Int J Dermatol. 1998;37:104.
  2. Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol. 2010;11:157.
  3. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classifcation criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151.
  4. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classifcation of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007; 110:1713.
  5. Akhyani M, Ghodsi ZS, Toosi S, et al. Erythroderma: a clinical study of 97 cases. BMC Dermatol. 2005;5:5.
  6. Martins GA, Arruda L. Tratamento sistêmico da psoríase - Parte I: metotrexato e acitretina. An Bras Dermatol. 2004;79(3):263-278.
  7. Izraeli S, Vora A, Zwaan CM, et al. How I treat ALL in Down’s syndrome: pathobiology and management. Blood. 2014;123:35.
  8. Ataíde DST, Esmanhoto LDK, Helmer KA, et al. Ulceração das placas psoriáticas - efeito cutâneo adverso do metotrexato em altas doses no tratamento da psoríase: relato de três casos. An Bras Dermatol. 2003;78:749-53.
  9. Mockenhaupt M, Dunant A, Paulmann M, et al. Drug Causality in Stevens‐Johnson Syndrome / Toxic Epidermal Necrolysis in Europe: Analysis of 10 Years RegiSCAR‐Study. Pharmacoepidemiol Drug Saf. 2016;25(Supp 3):3. 10. Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008;128:35.